Global Blood Therapeutics, Inc. - stock earnings
Stock symbol GBT is outdated, potentially delisted? Maybe it is available on other exchange?
GBT Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q2 | -82.5 million USD | 71.6 million USD |
| 2022Q1 | -81.4 million USD | 55.2 million USD |
| 2021Q4 | -87.6 million USD | 56.1 million USD |
| 2021Q3 | -71.0 million USD | 52.1 million USD |
| 2021Q2 | -69.6 million USD | 47.6 million USD |
| 2021Q1 | -74.9 million USD | 39.0 million USD |
| 2020Q4 | -61.8 million USD | 41.3 million USD |
| 2020Q3 | -59.9 million USD | 36.9 million USD |
| 2020Q2 | -52.8 million USD | 31.5 million USD |
GBT Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -303.1 million USD | 194.7 million USD |
| 2020 | -247.6 million USD | 123.8 million USD |
| 2019 | -266.8 million USD | 2.1 million USD |
| 2018 | -174.2 million USD | ? USD |
| 2017 | -117.0 million USD | ? USD |
GBT
Price: $68.49
52 week price:
Earnings Per Share: -2.90 USD
P/E Ratio: -9.31
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 3.3 million
Ebitda: -28.8 millionMarket Capitalization: 4.6 billion